Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • HyperFluor™ 594 Goat Anti-Rabbit IgG: Excellence in ICC & IH

    2026-04-22

    HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody: Transforming Immunofluorescence Workflows in Atherosclerosis and Beyond

    Principle and Setup: Unmatched Specificity for Fluorescence-Based Detection

    In the era of precision immunology, the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody stands out as an advanced goat anti-rabbit IgG secondary antibody, providing high sensitivity and specificity for detecting rabbit primary antibodies in complex tissue or cell samples. This polyclonal reagent, developed and quality-controlled by APExBIO, is affinity-purified and coupled to the HyperFluor™ 594 fluorophore (excitation 590 nm, emission 617 nm), ensuring exceptional brightness and minimal background (source: aimmunity.net). Its optimized formulation includes 1% BSA and 23% glycerol for stability and reliable performance, while sodium azide preserves integrity during storage.

    Researchers targeting immune regulators such as ISG20 and CLEC5A in atherosclerosis or other immune-mediated diseases benefit from the reagent’s robust performance in immunocytochemistry (ICC/IF), immunohistochemistry (IHC-Fr, IHC-P), flow cytometry (FC), and ELISA detection workflows (source: goat-anti-rabbit.com).

    Step-By-Step Workflow: Protocol Enhancements for Reproducible Results

    To maximize reproducibility and signal-to-noise ratio, follow this optimized workflow:

    1. Sample Preparation: For ICC/IF, fix cells with 4% paraformaldehyde for 10 minutes at room temperature. For IHC-P, dewax paraffin sections and rehydrate through graded alcohols.
    2. Blocking: Incubate samples with 5% normal goat serum in PBS for 30 minutes to minimize non-specific binding.
    3. Primary Antibody Incubation: Apply rabbit primary antibody (targeting ISG20, CLEC5A, etc.) at manufacturer-recommended dilution, typically overnight at 4°C for optimal epitope recognition.
    4. Washing: Wash samples 3 times with PBS to remove unbound primary antibody.
    5. Secondary Antibody Incubation: Dilute HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody as per protocol (see below), incubate for 1 hour at room temperature in the dark to protect the fluorophore.
    6. Final Washes and Mounting: Wash thoroughly. For microscopy, mount with an anti-fade medium and image promptly.

    Protocol Parameters

    • ICC/IF | 1:500–1:2000 dilution | Immunocytochemistry (fixed cells) | Ensures strong signal with minimal background; choose the lower dilution for low-abundance targets and higher for abundant ones | product_spec
    • IHC-P | 1:100–1:500 dilution | Paraffin-embedded tissue immunohistochemistry | Accommodates antigen retrieval variability and tissue density; optimal for robust detection in dense tissue | product_spec
    • Flow Cytometry | 1:250–1:1000 dilution | Flow cytometric detection of surface or intracellular markers | Provides bright, quantifiable signal; higher dilution minimizes non-specific staining in single-cell suspensions | product_spec
    • Incubation Time | 1 hour at room temperature (secondary antibody) | All workflows | Sufficient for antibody binding without compromising fluorophore stability | workflow_recommendation
    • Storage | Aliquot at 1 mg/mL, store at -20°C for up to 12 months | Reagent preservation | Avoids freeze-thaw cycles and light exposure, ensuring long-term signal fidelity | product_spec

    Key Innovation from the Reference Study: ISG20 and CLEC5A Detection in Atherosclerosis

    The pivotal study by Zhang et al. (Frontiers in Immunology) applied a powerful integration of Mendelian randomization and eQTL evidence to demonstrate that ISG20 and CLEC5A are upregulated in atherosclerosis, with ISG20 particularly enriched in endothelial and macrophage-rich regions of human and murine plaques. Notably, the study validated ISG20 expression using immunofluorescence co-staining and immunohistochemistry, revealing elevated signal intensity and spatial specificity (source: Frontiers in Immunology).

    Translating these findings into assay design, the use of a high-affinity, bright secondary antibody—such as HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L)—enables robust detection of subtle upregulation events and facilitates multiplexed co-localization with cell-type markers. The high signal-to-noise ratio and minimized cross-reactivity are critical for differentiating true biological changes from background, especially in the context of inflamed, heterogeneous tissues.

    Advanced Applications and Comparative Advantages

    Beyond single-marker detection, the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody is engineered for multiplexed immunofluorescence. Its spectral properties (excitation 590 nm, emission 617 nm) enable clean separation from common green and far-red fluorophores, supporting multi-color analysis of protein interactions and cellular phenotypes (source: aimmunity.net).

    In flow cytometry, the antibody’s brightness and low background empower sensitive detection of immune cell subsets, particularly when paired with other spectrally distinct fluorophores. For ELISA, its high specificity ensures reliable quantification, especially in sandwich assays involving rabbit primaries (source: streptavidin-hyperfluor.com).

    This product complements previous resources such as “Precision in ICC, IHC & FC” and “Elevating Immunofluorescence,” which highlight its value in multiplexed workflows and in studies dissecting immune mechanisms like ISG20/CLEC5A regulation. Compared to generic fluorescent secondary antibodies, APExBIO’s reagent delivers higher reproducibility and signal clarity, as documented across diverse assay formats (source: aimmunity.net).

    Troubleshooting and Optimization Tips

    • Non-Specific Staining: Increase blocking serum concentration to 10% or use commercial blocking agents. Consider pre-adsorbed secondary antibodies if multiplexing with primaries from similar species (workflow_recommendation).
    • Weak Signal: Verify primary antibody quality and optimize secondary antibody dilution within recommended range. Confirm proper storage and avoid repeated freeze-thaw cycles, which can degrade the fluorophore (source: product_spec).
    • Photobleaching: Protect sections from light throughout all steps and mount with anti-fade reagents. Minimize imaging time and avoid prolonged exposure to excitation light (workflow_recommendation).
    • Background Autofluorescence: For tissue with high intrinsic fluorescence, try quenching protocols (e.g., Sudan Black B) or select filter sets optimized for 594 nm emission (workflow_recommendation).
    • Signal Overlap in Multiplexing: Validate spectral compatibility between all fluorophores used. Use compensation controls for flow cytometry and spectral unmixing in confocal imaging (workflow_recommendation).

    Future Outlook: Empowering Discovery in Immunological Research

    The integration of robust secondary detection reagents, like HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody, continues to advance the frontiers of immunopathology and biomarker discovery. As multi-parameter imaging and single-cell analytics become routine, high-performance fluorescent conjugates will be indispensable for dissecting disease mechanisms, such as those in atherosclerosis (Zhang et al., 2025).

    With its proven track record in facilitating reproducible, high-sensitivity detection across ICC, IHC, FC, and ELISA, this APExBIO reagent will remain a mainstay in workflows requiring precision and multiplexing. Ongoing refinements in antibody purification and fluorophore chemistry promise even greater clarity, supporting the translation of molecular insights into therapeutic innovation (source: aimmunity.net).